Search in:

Advanced search

Nordic Journal of Psychiatry Volume 73, 2019 - Issue 4-5

Submit an article Journal homepage

189

Views

CrossRef citations to date

Altmetric

Articles

Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome

Nesrin KaramustafaliogluDepartment of Psychiatry, Bakırköy Mental Health Research and Training State Hospital, Istanbul, Turkey;

Tevfik KaleliogluDepartment of Psychiatry, Bakırköy Mental Health Research and Training State Hospital, Istanbul, Turkey; Correspondence[email protected]

http://orcid.org/0000-0001-9319-055X

Guler CelikelDepartment of Psychiatry, Bakırköy Mental Health Research and Training State Hospital, Istanbul, Turkey;

Abdullah GencDepartment of Psychiatry, Şişli Hamidiye Etfal Research and Training State Hospital, Istanbul, Turkey;

http://orcid.org/0000-0001-6691-1745

Murat EmulPrivate Psychiatry Center, Istanbul, Turkey

Pages 288-292 | Received 26 Sep 2018, Accepted 20 May 2019, Published online: 05 Jun 2019

Cite this article
https://doi.org/10.1080/08039488.2019.1623315
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477–492.
PubMed Web of Science ®Google Scholar
Moscovich M, Nóvak FTM, Fernandes AF, et al. Neuroleptic malignant syndrome. Arq Neuropsiquiatr. 2011;69:751–755.
PubMed Web of Science ®Google Scholar
Mathews T, Aderibigbe YA. Proposed research diagnostic criteria for neuroleptic malignant syndrome. Int J Neuropsychopharmacol. 1999;2:S1461145799001388.
Web of Science ®Google Scholar
Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–1145.
PubMed Web of Science ®Google Scholar
Gurrera RJ, Caroff SN, Cohen A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011;72:1222–1228.
PubMed Web of Science ®Google Scholar
Pileggi DJ, Cook AM. Neuroleptic malignant syndrome. Ann Pharmacother. 2016;50:973–981.
PubMed Web of Science ®Google Scholar
Rosebush PI, Mazurek MF, Mazurek MF. Serum iron and neuroleptic malignant syndrome. Lancet. 1991;338:149–151.
PubMed Web of Science ®Google Scholar
Rosebush PI, Anglin RE, Richards C, et al. Neuroleptic malignant syndrome and the acute phase response. J Clin Psychopharmacol. 2008;28:459–461.
PubMed Web of Science ®Google Scholar
Anglin RE, Rosebush PI, Mazurek MF. Neuroleptic malignant syndrome: a neuroimmunologic hypothesis. CMAJ. 2010;182:E834–8.
PubMed Web of Science ®Google Scholar
Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.
PubMedGoogle Scholar
Kalelioglu T, Akkus M, Karamustafalioglu N, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder. Psychiatry Res. 2015;228:925–927.
PubMed Web of Science ®Google Scholar
Özdin S, Sarisoy G, Böke Ö. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file review. Nord J Psychiatry. 2017;71:509–512.
PubMed Web of Science ®Google Scholar
Semiz M, Yildirim O, Canan F, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiatr Danub. 2014;26:220–225.
PubMed Web of Science ®Google Scholar
Kulaksizoglu B, Kulaksizoglu S. Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia. Neuropsychiatr Dis Treat. 2016;12:1999–2005.
PubMed Web of Science ®Google Scholar
Atli A, Demir S, Bulut M, et al. Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat. 2015;11:2253.
PubMed Web of Science ®Google Scholar
Forget P, Khalifa C, Defour J-P, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10:12.
PubMedGoogle Scholar
Gürol G, Çiftci İH, Terizi HA, et al. Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol. 2015;25:521–525.
PubMed Web of Science ®Google Scholar
Gurrera RJ, Romero JA. Sympathoadrenomedullary activity in the neuroleptic malignant syndrome. Biol Psychiatry. 1992;32:334–343.
PubMed Web of Science ®Google Scholar
Gurrera RJ. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry. 1999;156:169–180.
PubMed Web of Science ®Google Scholar
Berardi D, Amore M, Keck PE, et al. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry. 1998;44:748–754.
PubMed Web of Science ®Google Scholar
Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry. 1989;146:717–725.
PubMed Web of Science ®Google Scholar
Fitzgerald B, Middleton JK, Cooper SA. Adverse effects of summer amongst people with learning disabilities: neuroleptic malignant syndrome. J Intellect Disabil Res. 1997;41:273–277.
PubMed Web of Science ®Google Scholar
Kiank C, Koerner P, Kessler W, et al. Seasonal variations in inflammatory responses to sepsis and stress in mice. Crit Care Med. 2007;35:2352–2358.
PubMed Web of Science ®Google Scholar
Liu B, Taioli E. Seasonal variations of complete blood count and inflammatory biomarkers in the US population – analysis of NHANES data. PLoS One. 2015;10:e0142382.
PubMed Web of Science ®Google Scholar
Gurrera RJ. A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency. Acta Psychiatr Scand. 2017;135:398–408.
PubMed Web of Science ®Google Scholar
Jahan MS, Farooque AI, Wahid Z. Neuroleptic malignant syndrome. J Natl Med Assoc. 1992;84:966–970.
PubMed Web of Science ®Google Scholar
Chandrashekara S, Rajendran A, Bai Jaganath A, et al. Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis. Reumatismo. 2015;67:109–115.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date